[Dr.Vad]

в/в феринджект детям до 18 лет, подробно обо всем в полном тексте

A retrospective cohort of 144 consecutive patients aged 18 months to<18 years with iron deficiency anemia (IDA) or iron deficiency (ID) without anemia was investigated. All patients had failed oral iron therapy.

100 of 117 (85 %) of patients with complete data achieved the target ferritin level≥30 µg/L after a single FCM dose.
Of 77 patients with IDA and complete data, 38 (49%) showed a complete hematological response within 6-12*weeks; a complete or partial response was achieved by 83%.
Clinical symptoms improved in 85% of all patients. In 92% of patients (n=133 /144), FCM infusion was uneventful.
During the 96-hour follow-up, 5 patients reported potentially related symptoms. No serious adverse events occurred.

Intravenous ferric carboxymaltose for iron deficiency anemia or iron deficiency without anemia after poor response to oral iron treatment: Benefits and risks in a cohort of 144 children and adolescents [Ссылки доступны только зарегистрированным пользователям ]